5 Best Performing Healthcare ETFs in 2022

2. VanEck Pharmaceutical ETF (NASDAQ:PPH)

YTD Return as of December 9: 2.08%

The VanEck Pharmaceutical ETF (NASDAQ:PPH) uses a full replication technique to track the returns of the MVIS US Listed Pharmaceutical 25 Index. The fund has gained 2.08% year to date, as of December 9, and has outperformed the S&P 500 by roughly 20%. The fund ranks among the best performing healthcare ETFs in 2022 and has an expense ratio of 0.35%.

The VanEck Pharmaceutical ETF (NASDAQ:PPH) has 26 holdings and a top ten holdings concentration of 57.65%. Among the fund’s most prominent holdings we have Pfizer Inc. (NYSE:PFE). As of September 30, AQR Capital Management is the top investor in Pfizer Inc. (NYSE:PFE) and has a position worth $467.5 million in the company.

On November 17, Credit Suisse analyst Trung Huynh started coverage of Pfizer Inc. (NYSE:PFE) with an Outperform rating and a $55 price target.

Here is what Diamond Hill Capital had to say about Pfizer Inc. (NYSE:PFE) in its third-quarter 2022 investor letter:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.